Literature DB >> 32609429

Raman spectroscopy-based detection of RNA viruses in saliva: A preliminary report.

Sanket Desai1,2, Saket V Mishra3,2, Asim Joshi1,2, Debashmita Sarkar3,2, Arti Hole4, Rohit Mishra1,2, Shilpee Dutt3,2, Murali K Chilakapati4,2, Sudeep Gupta5,2, Amit Dutt1,2,6.   

Abstract

Several non-invasive Raman spectroscopy-based assays have been reported for rapid and sensitive detection of pathogens. We developed a novel statistical model for the detection of RNA viruses in saliva, based on an unbiased selection of a set of 65 Raman spectral features that mostly attribute to the RNA moieties, with a prediction accuracy of 91.6% (92.5% sensitivity and 88.8% specificity). Furthermore, to minimize variability and automate the downstream analysis of the Raman spectra, we developed a GUI-based analytical tool "RNA Virus Detector (RVD)." This conceptual framework to detect RNA viruses in saliva could form the basis for field application of Raman Spectroscopy in managing viral outbreaks, such as the ongoing COVID-19 pandemic. (http://www.actrec.gov.in/pi-webpages/AmitDutt/RVD/RVD.html).
© 2020 WILEY-VCH GmbH.

Entities:  

Keywords:  GUI-based automated computational analysis; RNA virus; Raman spectroscopy; linear discriminant analysis; principal component analysis

Mesh:

Year:  2020        PMID: 32609429      PMCID: PMC7361326          DOI: 10.1002/jbio.202000189

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.390


INTRODUCTION

Early identification of SARS‐CoV‐2 in infected patients is central to controlling COVID‐19 pandemic with no available treatment option or vaccine [1]. The current trend for prescribing diagnostic assays for those expressing salient symptoms of the disease may be suboptimal in impeding the transmission rate [2, 3]. Raman spectroscopy, based on the principle of inelastic scattering of light [4], is known to detect HIV, dengue, and various biomarkers and could potentially address practical concerns related to mass testing as a point‐of‐care device [5, 6, 7, 8]. A recent study described a comparable sensitivity of SARS‐CoV‐2 detection in the saliva of an asymptomatic COVID‐19 patient [9], consistent with an accelerated emergency use authorization approval to a saliva‐based diagnostic kit by the US FDA [10]. Saliva, thus, offers an attractive, quick, non‐invasive alternative to nasopharyngeal swabs for SARS‐CoV‐2 detection.

EXPERIMENTAL

We set to record Raman spectra to identify the presence of RNA virions, generated using pLL 3.7 lentivirus vector system (based on HIV‐1), with 7.05 × 107 TU/mL stock titer spiked in water and human saliva at 1:10 and 1:1000 dilutions. The infectivity of the viral particles was simultaneously confirmed by the observation of GFP expression in HEK293FT cells (Figure S1). Reported spectral data from saliva of individuals not known to have viral infection was used as a negative control [11].

RESULTS AND DISCUSSION

A set of 15 spectra were recorded from each sample, generating a total of 201 spectra, including 131 from viral negative samples, 54 from viral positive samples spiked with lentiviral RNA particles and 16 viral positive samples with enzymatic treatments (Table S1). Pre‐processed spectra post‐base‐line correction and area normalization interpolated in 600 to 1800 cm−1 region were used as inputs for downstream analysis. Principal component analysis (PCA) of all spectra revealed homogenous clustering of the two groups, with PC1 and PC2 accounting for 76.6% variance of the total sample set (Figure S2). Next, an unbiased prediction model was generated using linear discriminant analysis (LDA) based on spectral features with an SD of greater than 0.404 (marking the top quantile—308 features of 1200), and samples divided into training (n = 149) and test (n = 36) sets, showed a prediction accuracy of 88%. To obtain optimal number of features and refine the model, we used varying number top features from the principal components (PC1 and PC2) to build the model and computed prediction accuracy for each of them. Top 10, 25, 50, 75 and 100 features were iteratively used to build the model, wherein we observed that the model based on top 50 features from PC1 and PC2 (unique 65), achieved the highest accuracy (Figure S3). These 65 features (within the range of 939‐1054 cm−1) were adequate to effectively discern the viral positive and negative samples, as represented in the form of heatmap, increasing the model prediction accuracy to 91.6% (92.5% sensitivity and 88.8% specificity) (Figure 1A and Figure S2), which may be subject to a minor variability due to saliva‐specific spectral interferences.
FIGURE 1

A Raman spectroscopy‐based model to detect RNA viruses. A, Heatmap representation of the 1200 features from the virus positive and negative training sample set of Raman spectra with the zoomed‐out version showing the peak intensities for the features selected (n = 65) for model construction. The table shows the overall sample statistics and summary of the performance of the 65‐feature linear discriminant analysis‐based model for prediction of viral presence in the human saliva samples. B, Comparison of Raman spectra peaks between virus positive, virus negative and RNase‐treated viral positive sample for RNA‐specific constituents: the nitrogenous uracil base, ribose‐phosphate and A/G ring at 780, 1044 and 1480 cm−1, respectively by Wilcoxon rank‐sum test

A Raman spectroscopy‐based model to detect RNA viruses. A, Heatmap representation of the 1200 features from the virus positive and negative training sample set of Raman spectra with the zoomed‐out version showing the peak intensities for the features selected (n = 65) for model construction. The table shows the overall sample statistics and summary of the performance of the 65‐feature linear discriminant analysis‐based model for prediction of viral presence in the human saliva samples. B, Comparison of Raman spectra peaks between virus positive, virus negative and RNase‐treated viral positive sample for RNA‐specific constituents: the nitrogenous uracil base, ribose‐phosphate and A/G ring at 780, 1044 and 1480 cm−1, respectively by Wilcoxon rank‐sum test Intriguingly, a majority of bands in this range are attributable to RNA moieties, especially the ribose sugars in the 900‐1045 cm−1 range with a distinct peak at 1045 cm−1 and the phosphate group in 1080 to 1100 cm−1 range [12, 13]. Of note, biomolecules, such as DNA, RNA, proteins, lipids, from intact viruses are known to display unique Raman spectra vibrations based on their structural heterogeneity [14]. Thus, to ask if individual RNA moieties could determine the presence of RNA viruses, we performed an unbiased statistical analysis using Wilcoxon rank‐sum test for RNA specific constituent, such as for the nitrogenous uracil base, ribose‐phosphate and A/G ring at 780, 1044 and 1480 cm−1, respectively [12, 13]. Interestingly, all the RNA specific distinct peaks could. individually discern the viral positive and negative samples with high statistical confidence that was significantly reduced following RNase treatment (Figure 1B), but not with DNase or Proteinase treatment of the viral positive samples (Figure S4). Taken together, these results suggest a novel concept of using 65‐feature spectra (majorly attributable to RNA moieties) obtained from intact virion to form the basis for the detection of RNA viruses in human sputum. To minimize variability and automate the downstream 65‐feature‐based analysis of the Raman spectra we further developed a GUI‐based analytical tool RNA Virus Detector, RVD (http://www.actrec.gov.in/pi-webpages/AmitDutt/RVD/RVD.html), an in silico automated tool to detect RNA virus from an individual or a group of samples in an unambiguous and reproducible manner using the raw SPC files recorded by Raman spectrometer as an input for analysis, with minimal requirement of third‐party tools. The RVD accuracy based on the statistical model developed, however, may be limited by the spectral acquisition conditions such as excitation wavelength the laser power and the spectrograph employed, that may necessitate further improvisation for universal application.

MATERIALS AND METHODS

Sample collection

One sample of approximately 1 mL of unstimulated saliva of the principal investigator of this study was collected in sterile micro centrifuge to be used as a medium for studying the viral spectra spiked in the saliva for this study. The tube and was immediately refrigerated at 4°C. The samples were then transferred to −20°C till further use.

Transfection

1 × 106 HEK293FT cells were seeded per well on a 6‐well plate. The following day, transfection of GFP‐tagged lentiviral vector, pLL3.7 along with the packaging plasmids pPAX and pVSVG in 2:1:0.5 ratio using lipofectamine 3000 was performed according to manufacturer's instructions. The viral supernatant was collected 48‐ and 72‐hours post‐transfection, filtered using 0.45‐μ filter and subjected to ultracentrifugation at 30 000 rpm for 90 minutes at 4°C. The pellet was resuspended in 1 mL serum‐free Dulbecco's Modified Eagle's medium (DMEM) media [15].

Transduction

1.5 × 106 HEK293FT cells were seeded in 60 mm tissue culture petri‐dish. The next day, transduction of the viral particles were performed using two dilutions (1:10; 1:1000) in plain DMEM using 8 μg/mL polybrene in HEK293FT cells. GFP‐positive cells were observed 48 hours post‐transduction [15].

Sample preparation for Raman spectroscopy

Concentrate viral particle stock of 7.05 × 107 TU/mL were diluted in 1:10 and 1:1000 ratios using two different diluents‐ sterile ultrapure water and human saliva to mimic the patient condition. Plain media in ultrapure water and saliva without viral particles were taken as negative controls. Besides, to check the specific biomolecule (DNA, RNA or proteins) which help in differentiation of viral particles, the samples were treated with either DNase or RNase or Proteinase K, respectively.

Raman spectroscopy

Viral samples were subjected to Raman Spectroscopy by loading 20 μL on calcium fluoride (CaF2) window. Raman spectra were recorded using a WITec Raman alpha300R (WITec, GmbH, Germany) confocal microscope. In the 500 to 3800 cm−1 range, Raman spectra (ex 532 nm, 8 mW, 100X Zeiss 1.46 NA) were acquired using 50 μm fiber and directed to a 300 mm spectrograph equipped with 600 g/mm grating and thermo‐cooled CCD. Spectra were integrated for 10 seconds and averaged over 10 accumulations. On average, 15 spectra were recorded from each sample at a constant temperature of 20°C. Pre‐processed spectra, that is, base‐line corrected, area normalized and interpolated in 600 to 1800 cm−1 region were used as inputs for further data analysis [6, 16].

Spectra analysis, virus prediction model and tool development

Raman spectroscopy files (SPC) were converted to the CSV format using SPC python package (https://github.com/rohanisaac/spc), data normalization and statistical analysis were performed in the R programming environment (https://www.r-project.org/). Data pre‐processing and linear discriminant analysis was performed using the caret (https://topepo.github.io/caret/) and MASS (https://cran.r-project.org/web/packages/MASS/) package, respectively. Caret package was also used to perform k‐fold cross‐validation to check for the effect of data‐splitting on model prediction accuracy. Mean accuracy over 10‐folds, was found to be 93% (min: 84.21%, max: 100%, median: 94.59%, Kappa statistic 0.847). RVD was developed in python and R, and python Tkinter (https://docs.python.org/3/library/tkinter.html) library was used for development of the GUI.

CONCLUSION

We describe a string proof of concept method using Raman spectroscopy to detect the RNA viruses in saliva with a detection sensitivity of 7.05 × 107 TU/mL viral particles. This provides the essential framework for field application of Raman Spectroscopy‐based RVD in monitoring and responding to the COVID‐19 pandemic, wherein 106–1011 viral RNA copies/mL of saliva is reported [17, 18]. The positive tests could be validated by follow‐up testing with molecular biology laboratory‐based diagnosis to confirm the status of SARS‐CoV‐2, while epidemiological containment measures are implemented for the individual.

CONFLICT OF INTEREST

The authors declare no financial or commercial conflict of interest.

AUTHOR CONTRIBUTIONS

Sanket Desai, Saket V. Mishra, Asim Joshi, Murali K. Chilakapati and Amit Dutt designed research. Sanket Desai, Saket V. Mishra, Asim Joshi and Arti Hole performed research. Shilpee Dutt, Saket V. Mishra, Asim Joshi, Murali K. Chilakapati, Shilpee Dutt, Sudeep Gupta and Amit Dutt analyzed data. Sanket Desai developed the RVD. Rohit Mishra developed the GUI. Shilpee Dutt, Debashmita Sarkar and Amit Dutt wrote the paper. Figure S1 Infection competent viral particles show distinct spectra in saliva. A, Representative microscopy images of GFP‐positive HEK293FT cells transduced with pLL3.7 viral particles in 1:10 and 1:1000 dilutions under ×10 objective. B, Representative Raman spectra of saliva spiked with viral particles in 1:10 and 1:1000 dilutions Click here for additional data file. Figure S2 Principal component analysis‐based clustering of the samples. A, Principal component analysis plot based on the overall spectra in the 600–1800 cm−1 fingerprint region of virus‐positive and virus‐negative samples, wherein PC1 and PC2 explained 76.6%variance of the total sample set. B, Plot showing correlation of PC1 and PC2 with the selected 65 features used in model development. All the features positively correlate with the PC2 whereas, 56 features show a positive correlation with PC1 and rest are negatively correlated Click here for additional data file. Figure S3 Line plot depicting the prediction accuracy for models build from selection of number of features from PC1 and PC2. Click here for additional data file. Figure S4 Aligned Raman spectral of saliva spiked with 1:10 diluted intact viral particles in presence of RNase, DNase and Proteinase K is shown. The three RNA‐specific spectra intensity at 780, 1044 and 1480 cm −1 (marked by parallel vertical dotted lines) are significantly perturbed following RNase treatment, but not with DNase or Proteinase K treatment Click here for additional data file. Table S1 Statistical details of the samples used in the study along with their respective number of spectra Click here for additional data file.
  10 in total

1.  Raman spectroscopic signatures of echovirus 1 uncoating.

Authors:  Päivi Ruokola; Elina Dadu; Artur Kazmertsuk; Heikki Häkkänen; Varpu Marjomäki; Janne A Ihalainen
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

2.  Raman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementia.

Authors:  Elena Ryzhikova; Oleksandr Kazakov; Lenka Halamkova; Dzintra Celmins; Paula Malone; Eric Molho; Earl A Zimmerman; Igor K Lednev
Journal:  J Biophotonics       Date:  2014-09-25       Impact factor: 3.207

3.  Rapid Discrimination of Malaria- and Dengue-Infected Patients Sera Using Raman Spectroscopy.

Authors:  Sandip K Patel; Nishant Rajora; Saurabh Kumar; Aditi Sahu; Sanjay K Kochar; C Murali Krishna; Sanjeeva Srivastava
Journal:  Anal Chem       Date:  2019-05-17       Impact factor: 6.986

Review 4.  Raman crystallography of RNA.

Authors:  Bo Gong; Jui-Hui Chen; Rieko Yajima; Yuanyuan Chen; Elaine Chase; Durga M Chadalavada; Barbara L Golden; Paul R Carey; Philip C Bevilacqua
Journal:  Methods       Date:  2009-05-04       Impact factor: 3.608

5.  Serum based diagnosis of asthma using Raman spectroscopy: an early phase pilot study.

Authors:  Aditi Sahu; Krishna Dalal; Sarla Naglot; Parveen Aggarwal; C Murali Krishna
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

6.  Viral load of SARS-CoV-2 in clinical samples.

Authors:  Yang Pan; Daitao Zhang; Peng Yang; Leo L M Poon; Quanyi Wang
Journal:  Lancet Infect Dis       Date:  2020-02-24       Impact factor: 25.071

7.  Raman spectroscopy-based detection of RNA viruses in saliva: A preliminary report.

Authors:  Sanket Desai; Saket V Mishra; Asim Joshi; Debashmita Sarkar; Arti Hole; Rohit Mishra; Shilpee Dutt; Murali K Chilakapati; Sudeep Gupta; Amit Dutt
Journal:  J Biophotonics       Date:  2020-08-10       Impact factor: 3.390

8.  ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.

Authors:  Prajish Iyer; Shailesh V Shrikhande; Malika Ranjan; Asim Joshi; Nilesh Gardi; Ratnam Prasad; Bhasker Dharavath; Rahul Thorat; Sameer Salunkhe; Bikram Sahoo; Pratik Chandrani; Hitesh Kore; Bhabani Mohanty; Vikram Chaudhari; Anuradha Choughule; Dhananjay Kawle; Pradip Chaudhari; Arvind Ingle; Shripad Banavali; Poonam Gera; Mukta R Ramadwar; Kumar Prabhash; Savio George Barreto; Shilpee Dutt; Amit Dutt
Journal:  Int J Cancer       Date:  2018-12-08       Impact factor: 7.396

Review 9.  Diagnosing COVID-19: The Disease and Tools for Detection.

Authors:  Buddhisha Udugama; Pranav Kadhiresan; Hannah N Kozlowski; Ayden Malekjahani; Matthew Osborne; Vanessa Y C Li; Hongmin Chen; Samira Mubareka; Jonathan B Gubbay; Warren C W Chan
Journal:  ACS Nano       Date:  2020-03-30       Impact factor: 15.881

10.  SARS-CoV-2 (COVID-19) by the numbers.

Authors:  Yinon M Bar-On; Avi Flamholz; Rob Phillips; Ron Milo
Journal:  Elife       Date:  2020-04-02       Impact factor: 8.140

  10 in total
  15 in total

1.  Fluorescence spectrophotometry for COVID-19 determination in clinical swab samples.

Authors:  Kartika A Madurani; Muhammad Yudha Syahputra; Ika Puspita; Abdul Hadi Furqoni; Listya Puspasari; Hafildatur Rosyidah; Agus Muhamad Hatta; Maria Inge Lusida; Masato Tominaga; Fredy Kurniawan
Journal:  Arab J Chem       Date:  2022-05-30       Impact factor: 6.212

2.  An efficient primary screening of COVID-19 by serum Raman spectroscopy.

Authors:  Gang Yin; Lintao Li; Shun Lu; Yu Yin; Yuanzhang Su; Yilan Zeng; Mei Luo; Maohua Ma; Hongyan Zhou; Lucia Orlandini; Dezhong Yao; Gang Liu; Jinyi Lang
Journal:  J Raman Spectrosc       Date:  2021-02-19       Impact factor: 2.727

Review 3.  Optical technologies for the detection of viruses like COVID-19: Progress and prospects.

Authors:  Jijo Lukose; Santhosh Chidangil; Sajan D George
Journal:  Biosens Bioelectron       Date:  2021-01-16       Impact factor: 12.545

4.  Diagnosing COVID-19 in human serum using Raman spectroscopy.

Authors:  Ana Cristina Castro Goulart; Landulfo Silveira; Henrique Cunha Carvalho; Cristiane Bissoli Dorta; Marcos Tadeu T Pacheco; Renato Amaro Zângaro
Journal:  Lasers Med Sci       Date:  2022-01-14       Impact factor: 2.555

5.  Detection of inaccessible head and neck lesions using human saliva and fluorescence spectroscopy.

Authors:  Pavan Kumar
Journal:  Lasers Med Sci       Date:  2021-10-12       Impact factor: 2.555

Review 6.  Spectroscopy: a versatile sensing tool for cost-effective and rapid detection of novel coronavirus (COVID-19).

Authors:  Ujjal Kumar Sur; Chittaranjan Santra
Journal:  Emergent Mater       Date:  2022-02-28

7.  Detection of SARS-CoV-2 and its S and N proteins using surface enhanced Raman spectroscopy.

Authors:  John Eder Sanchez; Sierra A Jaramillo; Erik Settles; J Jesus Velazquez Salazar; Alexander Lehr; Javier Gonzalez; Carmen Rodríguez Aranda; Hugo R Navarro-Contreras; Marlee O Raniere; Maxx Harvey; David M Wagner; Andrew Koppisch; Robert Kellar; Paul Keim; Miguel Jose Yacaman
Journal:  RSC Adv       Date:  2021-07-26       Impact factor: 4.036

8.  Raman spectroscopy-based detection of RNA viruses in saliva: A preliminary report.

Authors:  Sanket Desai; Saket V Mishra; Asim Joshi; Debashmita Sarkar; Arti Hole; Rohit Mishra; Shilpee Dutt; Murali K Chilakapati; Sudeep Gupta; Amit Dutt
Journal:  J Biophotonics       Date:  2020-08-10       Impact factor: 3.390

Review 9.  Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition.

Authors:  Sushmita Patra; Rout George Kerry; Ganesh Kumar Maurya; Bijayananda Panigrahi; Swati Kumari; Jyoti Ranjan Rout
Journal:  Front Microbiol       Date:  2020-10-20       Impact factor: 5.640

Review 10.  Challenges with Simulating Modified RNA: Insights into Role and Reciprocity of Experimental and Computational Approaches.

Authors:  Rebecca J D'Esposito; Christopher A Myers; Alan A Chen; Sweta Vangaveti
Journal:  Genes (Basel)       Date:  2022-03-18       Impact factor: 4.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.